Which record must be maintained when selling controlled substances to a practitioner?

When selling controlled substances to a practitioner, it is essential to maintain a record of the DEA 222 form, which is the appropriate documentation for the transfer of Schedule I and II controlled substances. The DEA 222 form is a triplicate order form that is required by the Drug Enforcement Administration (DEA) when a pharmacy sells or transfers controlled substances to another registrant, such as a practitioner or another pharmacy.

This form serves several purposes: it ensures proper tracking of controlled substances to prevent misuse and diversion, maintains compliance with federal regulations, and creates a paper trail that can be audited by the DEA or other regulatory bodies. The correct and accurate completion of the DEA 222 form is crucial in showcasing that the pharmacy is adhering to laws governing the distribution of controlled substances.

In contrast, the other options listed do not serve as the primary record necessary for such a transaction. For example, while a patient's prescription history is important for patient safety and medication management, it does not fulfill the regulatory requirement for documenting the sale of controlled substances to practitioners. Similarly, a pharmacist's license and insurance information are important for different aspects of pharmacy operation but are not specifically required for tracking controlled substance sales.